Cuorips

Cuorips EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Cuorips (4894.T) as of Oct 17, 2026 is -81.55. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -105.26 — a change of -22.53% (higher).

EV/OCF

-81.55

YoY

-22.53%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Cuorips is 2026 -81.55 . EV/OCF (Enterprise Value to Operating Cash Flow) of Cuorips was 2025 -105.26 . It decreases by -22.53% higher compared to the previous year.

The Cuorips EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2021
-306.90 JPY
Jan 1, 2022
-394.05 JPY
Jan 1, 2023
-217.60 JPY
Jan 1, 2024
-187.89 JPY
Jan 1, 2025
-105.26 JPY
Jan 1, 2026
-81.55 JPY
The Cuorips EV/OCF history
YEAREV/OCFYoY
-81.55-22.53%
-105.26-43.98%
-187.89-13.65%
-217.60-44.78%
-394.05+28.40%
-306.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cuorips Stock analysis

What does Cuorips do? Cuorips Inc is a Japanese company operating in the Health Care sector, specifically within Biotechnology. Headquartered in Chuo-Ku, Tokyo, the company focuses on the development and commercialization of regenerative medical products, with a particular emphasis on human iPS cell-derived cardiomyocyte sheets. Cuorips also engages in a contract development and manufacturing organization (CDMO) business, utilizing its CLiC-1 facility, a commercial cell culture and processing center designed according to the company's original concept. The company has 46 full-time employees and completed its initial public offering (IPO) on June 27, 2023. Cuorips collaborates with universities, research institutions, and major pharmaceutical companies for in-house research and joint research initiatives. Its primary product, human iPS cell-derived cardiomyocyte sheets, is targeted at regenerative medical applications for the heart and other areas. The company's website is https://cuorips.co.jp/. Cuorips is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cuorips stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Cuorips is -81.55 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Cuorips changed from -105.26 to -81.55, representing a -22.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Cuorips since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Cuorips with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cuorips

All Key Metrics — Cuorips